Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 1/20 | 0.72 |
| ▸ | PYGM | P11217 | 3/20 | 0.50 |
| ▸ | TK2 | O00142 | 2/20 | 0.47 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.45 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.45 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31685747 | 0.90 | DNPH1 (0.58) | DNPH1PYGMTK2P2RY2 | |
| SCHEMBL31685257 | 0.88 | DNPH1 (0.55) | DNPH1PYGMTK2P2RY6P2RY14 | |
| SCHEMBL1904388 | 0.87 | TYMP (0.59) | DNPH1TK2 | |
| SCHEMBL31685507 | 0.85 | P2RY6 (0.61) | DNPH1PYGMP2RY6 | |
| SCHEMBL31685254 | 0.83 | DNPH1 (1.00) | DNPH1P2RY6P2RY14P2RY2 | |
| SCHEMBL14929135 | 0.82 | DNPH1 (0.71) | DNPH1PYGMTK2P2RY2 | |
| SCHEMBL14946378 | 0.82 | DNPH1 (0.71) | DNPH1PYGMTK2P2RY2 | |
| SCHEMBL14853793 | 0.82 | DNPH1 (0.71) | DNPH1PYGMTK2P2RY2 | |
| SCHEMBL263751 | 0.82 | DNPH1 (0.71) | DNPH1PYGMTK2P2RY2 | |
| SCHEMBL263750 | 0.82 | DNPH1 (0.71) | DNPH1PYGMTK2P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | DNPH1 2227/4885PYGM 1652/4885TK2 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.